James Schiff Topilow is a Hackensack, New Jersey based male rheumatologist who is specialized in Rheumatology. Active license number of James Schiff Topilow for Rheumatology is 25MA11784500 in New Jersey. James Schiff Topilow treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
James Schiff Topilow speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
385 Prospect Ave Ste 204, Hackensack, New Jersey, 07601-2570
Phone:
551-996-9244
Fax:
434-243-5770
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1568968683
NPI Enumeration Date:
05 Apr, 2018
NPI Last Update On:
11 Jan, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James Schiff Topilow are as mentioned below.
License Number
Specialization
State
Status
25MA11784500
Rheumatologist
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
385 Prospect Ave Ste 204, Hackensack, New Jersey
Zip:
07601-2570
Phone Number:
551-996-9244
Fax Number:
434-243-5770
Patients can reach James Schiff Topilow at 385 Prospect Ave Ste 204, Hackensack, New Jersey or can call to book an appointment on 551-996-9244. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.